Bulk Ginkgo Biloba Extract for Cognitive Health & Cardiovascular Support

Ginkgo Biloba Extract Overview

Ginkgo biloba extract (CAS 90045-36-6) is a standardized botanical extract prepared from the leaves of the Ginkgo biloba tree, a species whose traditional use in Asia and Europe spans many centuries. Commercial extracts are conventionally standardized to 24% flavone glycosides and 6% terpene lactones, in line with the monograph traditions of USP-NF and the European Pharmacopoeia (Ph.Eur.). Because the leaf material yields a multi-marker complex of flavonol glycosides and terpene lactones rather than one active molecule, the extract has no single molecular formula or molecular weight; its identity is defined by the CAS registry number together with the declared 24/6 marker system, which is how qualified buyers compare suppliers across regions.

Purecium supplies food-grade bulk Ginkgo biloba extract as USP 24/6 and EP 24/6 powders, produced from harvested leaves by aqueous and ethanolic extraction at an approximate 50:1 concentration ratio. The ingredient is among the most thoroughly documented botanicals in the European herbal tradition: the EMA Committee on Herbal Medicinal Products (HMPC) framework maintains community monographs covering Ginkgo biloba leaf preparations, and WHO monographs on medicinal plants include ginkgo leaf as a reference botanical, giving formulators a stable regulatory baseline across EU and global markets.

Source & Ingredient Identity

Ginkgo biloba extract is sourced from the leaves of cultivated ginkgo trees, harvested in a defined seasonal window and processed promptly to preserve the native flavonol glycoside and terpene lactone profile. Extraction uses aqueous or aqueous-ethanolic solvent systems, followed by concentration, purification, and drying to a free-flowing powder at an approximately 50:1 leaf-to-extract ratio. Under the USP-NF and Ph.Eur. monograph frameworks, identity is established by the CAS registry number 90045-36-6 together with the 24% flavone glycosides and 6% terpene lactones specification, qualifying the ingredient as a marker-standardized botanical rather than a single chemical entity.

Purecium offers two specification variants under one qualified sourcing program: Ginkgo Biloba Extract USP 24/6 Powder and Ginkgo Biloba Extract EP 24/6 Powder. The identity-relevant marker chemistry is anchored in the terpene lactone fraction, led by ginkgolide A (C20H24O9, molecular weight 408.40 g/mol) and bilobalide (C15H18O8, molecular weight 326.30 g/mol), together with the flavonol glycoside fraction, whose aglycones include quercetin (C15H10O7, molecular weight 302.23 g/mol) and kaempferol (C15H10O6, molecular weight 286.24 g/mol). These four marker structures form the analytical backbone of the USP-NF and European Pharmacopoeia test methods applied to commercial batches.

Key Characteristics of Ginkgo Biloba Extract

Ginkgo biloba extract presents as a brownish-yellow to yellowish-brown fine powder with a characteristic aromatic odor and slightly bitter taste. Release testing follows monograph limits: not less than 24% flavone glycosides and not less than 6% terpene lactones by HPLC, loss on drying below 5%, and heavy metals within USP-NF limits (lead below 2 ppm, arsenic below 2 ppm, cadmium below 1 ppm, and mercury below 0.1 ppm). The powder remains stable when protected from light, moisture, and heat in sealed original packaging, and the marker content is verified on every lot before release to confirm the 24/6 balance expected by the USP-NF and Ph.Eur. monographs.

Functionally, the flavonol glycoside fraction, quantified after hydrolysis as quercetin and kaempferol aglycones, contributes the antioxidant character associated with ginkgo leaf in research contexts, while the terpene lactone fraction (ginkgolides A, B, and C plus bilobalide) is the focus of mechanistic research on platelet-activating factor and neuronal signaling pathways. Within the European framework, EMA/HMPC and EFSA reference points treat ginkgo preparations as botanicals whose effects relate to the whole standardized marker complex rather than any single constituent, which is why the 24/6 specification governs both identity and release testing across commercial supply chains.

Ginkgo Biloba Extract Manufacturing

Ginkgo biloba extract is manufactured from leaves harvested at the correct maturity stage and dried under controlled conditions to lock in the marker profile. The dried leaf material undergoes aqueous-ethanolic extraction, and the liquid is concentrated and purified through steps designed to enrich the flavonol glycoside and terpene lactone fractions while removing chlorophyll, waxes, and other leaf-matrix components. Each purification stage is fixed in the master batch record so that the 24/6 marker balance is reproduced lot after lot under the analytical framework of USP-NF, and in-process samples are monitored by HPLC at every critical step, and the purified fraction is re-tested before it moves to the drying stage.

The purified concentrate is standardized to the declared 24% flavone glycosides and 6% terpene lactones, dried to a fine powder, and milled to a consistent particle size that supports capsule filling, tableting, and blending with other botanical actives. Finished powder is packed under low-humidity conditions in sealed food-grade drums with inner liners to protect the light- and moisture-sensitive markers during storage and transit. Real-time and accelerated stability programs confirm a 24-month shelf life, and stability summaries are compiled against the expectations of USP-NF and Ph.Eur. to support customer registration dossiers.

Applications of Ginkgo Biloba Extract

Ginkgo biloba extract is used by supplement brands and contract manufacturers in four primary application clusters. First, cognitive and memory formulas, where ginkgo is among the most widely studied botanicals for cognitive performance contexts in aging populations, as reflected in NIH Office of Dietary Supplements fact sheets and extensive published research. Second, circulatory and microcirculation positioning, building on the European herbal medicine tradition recognized under the EMA/HMPC framework for peripheral circulation support. Third, brain-health and nootropic blends, where ginkgo is combined with bacopa, phosphatidylserine, and DHA in cognitive stacks. Fourth, eye and ear health formulas, where research interest centers on sensory organ microcirculation.

Across commercial products, typical finished doses of standardized Ginkgo biloba extract range from 120-240 mg per day, normally divided into one or two servings, with the full 24/6 marker specification delivered from the concentrated powder. Purecium supports formulation teams with application guidance, compatibility data, and regulatory reference materials so ginkgo can be positioned confidently in tablets, capsules, softgels, sachets, and beverage premixes. Final dosage levels and claims are set by each brand's own regulatory review under the applicable EFSA or national food-supplement framework.

Manufacturing & Quality Control

Every commercial batch of Purecium Ginkgo biloba extract is produced under ISO 9001 and FSSC22000 certified quality systems in cGMP-compliant facilities with HACCP controls. Finished-product testing covers HPLC quantification of the full marker system: flavonol glycosides are determined by HPLC after acid hydrolysis and expressed as quercetin and kaempferol aglycones, while the terpene lactones ginkgolide A, ginkgolide B, ginkgolide C, and bilobalide are determined by direct HPLC against certified reference standards. Supporting analysis includes loss on drying, heavy metals within USP-NF and Ph.Eur. limits, and a full microbiological panel.

Solvent and pesticide control is a defining requirement for botanical extracts. Residual solvents are tested by USP and Ph.Eur. methods with individual limits typically below 5,000 ppm, and pesticide residues are screened against the limits applied by the European Pharmacopoeia and WHO for herbal materials, with results reported in parts per million. Each shipment is released with a Certificate of Analysis (CoA) documenting every measured parameter, accompanied by the Safety Data Sheet (SDS), allergen statement, non-GMO verification, and BSE/TSE-free certificate. Kosher and Halal certifications support distribution into religious-market segments.

Ginkgo Biloba Extract for B2B Supplement Manufacturing

Dietary supplement distributors, contract manufacturers (OEM/ODM), and terminal brand owners are served with bulk Ginkgo biloba extract USP 24/6 and EP 24/6 powders at a standard MOQ of 25 kg. Material is packed in 25 kg net food-grade fiber drums with double polyethylene liners, with a lead time of approximately 7-15 days after order confirmation for stock specifications. Logistics options include air freight, ocean container loads (FCL/LCL), and expedited courier dispatch, with warehousing support in the United States for rapid restocking of North American production lines, while EU and UK orders are dispatched directly from our export hub in China.

Commercial partners receive tiered volume pricing, pilot-scale samples for R&D evaluation, and batch-specific CoA documentation compiled in line with USP-NF and Ph.Eur. reporting formats so that flavonol glycoside and terpene lactone content can be entered directly into vendor qualification files. Purecium maintains over 15 years of nutraceutical export experience and a dedicated B2B account-management team that coordinates customs paperwork, stability summaries, and regulatory dossiers to keep launch timelines on schedule. Reviewed by the Chief Quality Assurance / Regulatory Affairs Specialist at Purecium for technical accuracy and regulatory alignment.